Valérie Pourcher

InstitutionAP-HP.Sorbonne Université
AddressParis
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 20 Covid-19 publications, with a maximum of 2 publications in July 2020 and Spetember 2020 and October 2020 and January 2021 and May 2021
    All Publications
    Bar chart showing 34 publications over 5 distinct years, with a maximum of 13 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Paccoud O, Tubach F, Baptiste A, Bleibtreu A, Hajage D, Monsel G, Tebano G, Boutolleau D, Klement E, Godefroy N, Palich R, Itani O, Faiçal A, Valantin MA, Tubiana R, Burrel S, Calvez V, Caumes E, Marcelin AG, Pourcher V. Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital. Clin Infect Dis. 2021 12 06; 73(11):e4064-e4072. PMID: 32556143.
      Citations: 22     Fields:    Translation:Humans
    2. Louapre C, Ibrahim M, Maillart E, Abdi B, Papeix C, Stankoff B, Dubessy AL, Bensa-Koscher C, Créange A, Chamekh Z, Lubetzki C, Marcelin AG, Corvol JC, Pourcher V. Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2022 01; 93(1):24-31. PMID: 34341142.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    3. Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837. PMID: 34048876.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    4. Hajage D, Pourcher V, Paccoud O, Bleibtreu A, Caumes E, Tubach F. Reply to Million et al. Clin Infect Dis. 2021 05 04; 72(9):e440-e441. PMID: 32761119.
      Citations:    Fields:    Translation:Humans
    5. Amoura Z, Miyara M, Tubach F, Pourcher V, Morélot-Panzini C, Haroche J, Gorochov G, Caumes E, Hausfater P, Combes A, Similowski T. [Letter to the editor regarding the article entitled «COVID-19 and medical publications: How three articles have influenced the media and public decisions in France»]. Rev Med Interne. 2021 08; 42(8):591-592. PMID: 33931228.
      Citations:    Fields:    Translation:Humans
    6. Zahr N, Urien S, Llopis B, Pourcher V, Paccoud O, Bleibtreu A, Mayaux J, Gandjbakhch E, Hekimian G, Combes A, Benveniste O, Saadoun D, Allenbach Y, Pinna B, Cacoub P, Funck-Brentano C, Salem JE. Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19. Therapie. 2021 Jul-Aug; 76(4):285-295. PMID: 33558079.
      Citations: 2     Fields:    Translation:Humans
    7. Laurenge A, Ursu R, Houillier C, Abdi B, Tebano G, Quemeneur C, Choquet S, Di Blasi R, Lozano F, Morales A, Durán-Peña A, Sirven-Villaros L, Mathon B, Mokhtari K, Bielle F, Martin-Duverneuil N, Delattre JY, Marcelin AG, Pourcher V, Alentorn A, Idbaih A, Carpentier AF, Leblond V, Hoang-Xuan K, Touat M. SARS-CoV-2 infection in patients with primary central nervous system lymphoma. J Neurol. 2021 Sep; 268(9):3072-3080. PMID: 33387015.
      Citations: 2     Fields:    Translation:Humans
    8. Klement E, Godefroy N, Burrel S, Kornblum D, Monsel G, Bleibtreu A, Marcelin AG, Calvez V, Caumes E, Boutolleau D, Pourcher V. The First Locally Acquired Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Healthcare Worker in the Paris Area. Clin Infect Dis. 2020 12 03; 71(9):e530-e531. PMID: 32211789.
      Citations: 4     Fields:    Translation:Humans
    9. Sessa A, Mazzola A, Lim C, Atif M, Pappatella J, Pourcher V, Scatton O, Conti F, Conti F. COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case report. World J Gastroenterol. 2020 Nov 28; 26(44):7076-7084. PMID: 33311951.
      Citations: 6     Fields:    Translation:Humans
    10. Burrel S, Hausfater P, Dres M, Pourcher V, Luyt CE, Teyssou E, Soulié C, Calvez V, Marcelin AG, Boutolleau D. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19. Int J Infect Dis. 2021 Jan; 102:10-13. PMID: 33115679.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    11. Nouchi A, Chastang J, Miyara M, Lejeune J, Soares A, Ibanez G, Saadoun D, Morélot-Panzini C, Similowski T, Amoura Z, Boddaert J, Caumes E, Bleibtreu A, Lorenzo A, Tubach F, Pourcher V. Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study. Eur J Clin Microbiol Infect Dis. 2021 Apr; 40(4):691-697. PMID: 33033955.
      Citations: 10     Fields:    Translation:Humans
    12. Delorme C, Paccoud O, Kas A, Hesters A, Bombois S, Shambrook P, Boullet A, Doukhi D, Le Guennec L, Godefroy N, Godefroy N, Maatoug R, Fossati P, Millet B, Navarro V, Navarro V, Bruneteau G, Demeret S, Pourcher V. COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. Eur J Neurol. 2020 12; 27(12):2651-2657. PMID: 32881133.
      Citations: 37     Fields:    Translation:Humans
    13. Maillart E, Papeix C, Lubetzki C, Roux T, Pourcher V, Louapre C. Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies? Mult Scler Relat Disord. 2020 Nov; 46:102482. PMID: 32916509.
      Citations: 11     Fields:    Translation:Humans
    14. Faury H, Courboulès C, Payen M, Jary A, Hausfater P, Luyt C, Dres M, Pourcher V, Abdi B, Wirden M, Calvez V, Marcelin AG, Boutolleau D, Burrel S. Medical features of COVID-19 and influenza infection: A comparative study in Paris, France. J Infect. 2021 02; 82(2):e36-e39. PMID: 32798533.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    15. Jary A, Leducq V, Malet I, Marot S, Klement-Frutos E, Teyssou E, Soulié C, Abdi B, Wirden M, Pourcher V, Caumes E, Calvez V, Burrel S, Marcelin AG, Boutolleau D. Evolution of viral quasispecies during SARS-CoV-2 infection. Clin Microbiol Infect. 2020 Nov; 26(11):1560.e1-1560.e4. PMID: 32717416.
      Citations: 31     Fields:    Translation:HumansCellsPHPublic Health
    16. Vespignani H, Colas D, Lavin BS, Soufflet C, Maillard L, Pourcher V, Paccoud O, Medjebar S, Frouin PY. Report on Electroencephalographic Findings in Critically Ill Patients with COVID-19. Ann Neurol. 2020 09; 88(3):626-630. PMID: 32533727.
      Citations: 17     Fields:    Translation:Humans
    17. Mazzola A, Kerbaul F, Atif M, Monsel A, Malaquin G, Pourcher V, Scatton O, Conti F, Conti F. The impact of Coronavirus 19 disease on liver transplantation in France: The sickest first approach? Clin Res Hepatol Gastroenterol. 2020 09; 44(4):e81-e83. PMID: 32646848.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    18. Klement-Frutos E, Burrel S, Peytavin G, Marot S, Lê MP, Godefroy N, Calvez V, Marcelin AG, Caumes E, Pourcher V, Boutolleau D. Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19. J Infect. 2021 01; 82(1):159-198. PMID: 32473230.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    19. Louapre C, Maillart E, Roux T, Pourcher V, Bussone G, Lubetzki C, Papeix C. Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum. Rev Neurol (Paris). 2020 06; 176(6):523-525. PMID: 32362357.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    Pourcher's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (201)
    Explore
    _
    Co-Authors (192)
    Explore
    _
    Similar People (60)
    Explore
    _